[Combined use of TUVP and TURP for prostate cancer with bladder outlet obstruction].
OBJECTIVE
To investigate a new surgical method for the treatment of prostate cancer with bladder outlet obstruction.


METHODS
Forty-seven patients with prostate cancer complicated with bladder outlet obstruction were treated by combined use of transurethral electrovaporization ablation of the prostate (TUVP) and transurethral resection of the prostate (TURP).


RESULTS
The operations were successful, with satisfactory results and no serious complication. IPSS decreased from (26.5 +/- 4.8) pre-operatively to (8.5 +/- 2.2) post-operatively (P < 0.05); Qmax increased from (4.6 +/- 1.5) ml/s to (14.5 +/- 3.6) ml/s (P < 0.05); and PSA decreased from (58.1 +/- 7.2) microg/L to (3.6 +/- 1.8) microg/L (P < 0.01).


CONCLUSIONS
The combined use of TUVP and TURP is a safe and ideal method for the treatment of prostate cancer with bladder outlet obstruction.
Yang
Guan-tian
GT
Department of Urology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, China. yang991117@yahoo.com.cn
Yao
Mao-yin
MY
Yang
Jian-jun
JJ
Yuan
Zhang
Z
Liu
Jing
J
Huo
Ming-dong
MD
Zhang
Xiao-wen
XW
D000368:Aged; D000369:Aged, 80 and over; D004598:Electrosurgery; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009919:Orchiectomy; D017430:Prostate-Specific Antigen / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000150:complications / Q000601:surgery*; D020728:Transurethral Resection of Prostate / Q000379:methods*; D016896:Treatment Outcome; D001748:Urinary Bladder Neck Obstruction / Q000150:complications / Q000601:surgery*
D017430:Prostate-Specific Antigen